AEMD - Company ID 0000882291
The table below shows AETHLON MEDICAL INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$1.71M | -$1.75M | -$2.48M | -$2.73M | -$2.07M | -$1.10M |
| Capital expenditure | - | $0.00 | $230.38K | $41.17K | $38.37K | $17.81K |
| Investing cash flow | - | $0.00 | -$230.38K | -$41.17K | -$38.37K | -$17.81K |
| Dividends paid | - | - | - |
AETHLON MEDICAL INC reported operating cash flow of -$7.65M for fiscal year 2025. That is up 24.5% from -$10.13M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$4.33M (FY 2016) to -$7.65M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$5.36K | $5.38M | $1.08M | $619.44K | $17.42M | $7.24M |